{"id":"doi:10.1016/s0140-6736(24)01643-x","kind":"article","title":"Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials","authors":["Mikhail Kosiborod","John Eric Deanfield","Richard E. Pratley","Barry A. Borlaug","Javed Butler","Melanie Jane Davies","Scott S. Emerson","Steven E. Kahn","Dalane W. Kitzman","Ildiko Lingvay","Kenneth W. Mahaffey","Mark Colquhoun Petrie","Jorge Plutzky","Søren Rasmussen","Cecilia Rönnbäck","Sanjiv Jayendra Shah","Subodh Verma","Peter Weeke","Abraham Michael Lincoff"],"author_count":19,"year":2024,"published":"2024-08-30","venue":"The Lancet","cited_by":313,"doi":"10.1016/s0140-6736(24)01643-x","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1016/s0140-6736(24)01643-x","archive_url":"https://space-kitty.com/papers/doi:10.1016/s0140-6736(24)01643-x","updated":null,"pmid":"39222642","pmcid":null,"openalex_id":"W4402066678","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":false,"retracted":false,"peer_reviewed":null,"categories":["Heart Failure Treatment and Management"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"glp1-metabolic","name":"GLP-1 & Incretin Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[{"slug":"glp1-metabolic","title":"GLP-1 & Incretin Therapies: State of the Field (October 2026)","url":"https://space-kitty.com/dossiers/glp1-metabolic"}]}